Clinical Trial

Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction - Beta Trial

Study acronym: iACTforDGBI
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess the acceptability, feasibility, and usability of the iACTforDGBI intervention among patients with Disorders of Gut-Brain Interaction (DGBI). The main question it aims to answer are: What are the perceptions of patients with DGBI and healthcare practitioners regarding the acceptability, feasibility, and usability of the iACTforDGBI intervention? Participants will be asked to: Complete the iACTforDGBI intervention prototype, consisting of self-guided online sessions. Participate in online interviews and fill out online questionnaires to evaluate the intervention concerning acceptability, feasibility, usability and preliminary effects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-09; most recent amendment 2026-02-13.
Status change: Recruiting → Completed 2026-02-13
Trial Details
NCT Number NCT07175402
Lead Sponsor Örebro University, Sweden
Collaborators: Sahlgrenska University Hospital, Göteborg University, Uppsala University
Conditions DGBI, Depression/Anxiety
Enrollment 27 participants
Start Date 2025-09-08
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-17